LymphedemaV1, Istex, Corpus, bibRecord, 006C49

Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer

Identifieur interne : 006C49 ( Istex/Corpus ); précédent : 006C48; suivant : 006C50

Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer

Auteurs : E. Jones ; D. Brizel ; M. Dewhirst ; A. Alvarez ; A. Berchuck ; D. Clarke-Pearson ; G. Rodriquez ; J. Soper ; L. Prosnitz

Source :

International Journal of Radiation Oncology, Biology, Physics [ 0360-3016 ] ; 2001.

RBID : ISTEX:E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2
Url:

https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/pdf

DOI: 10.1016/S0360-3016(01)01940-X

Links to Exploration step

ISTEX:E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
<author><name sortKey="Jones, E" sort="Jones, E" uniqKey="Jones E" first="E." last="Jones">E. Jones</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brizel, D" sort="Brizel, D" uniqKey="Brizel D" first="D." last="Brizel">D. Brizel</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dewhirst, M" sort="Dewhirst, M" uniqKey="Dewhirst M" first="M." last="Dewhirst">M. Dewhirst</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Alvarez, A" sort="Alvarez, A" uniqKey="Alvarez A" first="A." last="Alvarez">A. Alvarez</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Berchuck, A" sort="Berchuck, A" uniqKey="Berchuck A" first="A." last="Berchuck">A. Berchuck</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Clarke Pearson, D" sort="Clarke Pearson, D" uniqKey="Clarke Pearson D" first="D." last="Clarke-Pearson">D. Clarke-Pearson</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rodriquez, G" sort="Rodriquez, G" uniqKey="Rodriquez G" first="G." last="Rodriquez">G. Rodriquez</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Soper, J" sort="Soper, J" uniqKey="Soper J" first="J." last="Soper">J. Soper</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Prosnitz, L" sort="Prosnitz, L" uniqKey="Prosnitz L" first="L." last="Prosnitz">L. Prosnitz</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0360-3016(01)01940-X</idno>
<idno type="url">https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006C49</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006C49</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
<author><name sortKey="Jones, E" sort="Jones, E" uniqKey="Jones E" first="E." last="Jones">E. Jones</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brizel, D" sort="Brizel, D" uniqKey="Brizel D" first="D." last="Brizel">D. Brizel</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dewhirst, M" sort="Dewhirst, M" uniqKey="Dewhirst M" first="M." last="Dewhirst">M. Dewhirst</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Alvarez, A" sort="Alvarez, A" uniqKey="Alvarez A" first="A." last="Alvarez">A. Alvarez</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Berchuck, A" sort="Berchuck, A" uniqKey="Berchuck A" first="A." last="Berchuck">A. Berchuck</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Clarke Pearson, D" sort="Clarke Pearson, D" uniqKey="Clarke Pearson D" first="D." last="Clarke-Pearson">D. Clarke-Pearson</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rodriquez, G" sort="Rodriquez, G" uniqKey="Rodriquez G" first="G." last="Rodriquez">G. Rodriquez</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Soper, J" sort="Soper, J" uniqKey="Soper J" first="J." last="Soper">J. Soper</name>
<affiliation><mods:affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Prosnitz, L" sort="Prosnitz, L" uniqKey="Prosnitz L" first="L." last="Prosnitz">L. Prosnitz</name>
<affiliation><mods:affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">International Journal of Radiation Oncology, Biology, Physics</title>
<title level="j" type="abbrev">ROB</title>
<idno type="ISSN">0360-3016</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">51</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="supplement">S1</biblScope>
<biblScope unit="page" from="63">63</biblScope>
<biblScope unit="page" to="64">64</biblScope>
</imprint>
<idno type="ISSN">0360-3016</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0360-3016</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>brachytherapy</json:string>
<json:string>toxicity</json:string>
<json:string>cervical</json:string>
<json:string>cervix</json:string>
<json:string>node</json:string>
<json:string>cddp</json:string>
<json:string>pelvis</json:string>
<json:string>pelvic irradiation</json:string>
<json:string>intracavitary</json:string>
<json:string>hyperthermia</json:string>
<json:string>oncology</json:string>
<json:string>metastasis</json:string>
<json:string>cervix cancer</json:string>
<json:string>chemotherapy</json:string>
<json:string>relapse</json:string>
<json:string>guideline</json:string>
<json:string>cervical cancer</json:string>
<json:string>randomized</json:string>
<json:string>radiation therapy</json:string>
<json:string>gung</json:string>
<json:string>chang</json:string>
<json:string>recurrence</json:string>
<json:string>dose rates</json:string>
<json:string>radiation dose</json:string>
<json:string>pathological risk factors</json:string>
<json:string>intracavitary brachytherapy</json:string>
<json:string>whole pelvis</json:string>
<json:string>dose rate</json:string>
<json:string>overall survival</json:string>
<json:string>local control</json:string>
<json:string>late toxicity</json:string>
<json:string>implant</json:string>
<json:string>median</json:string>
<json:string>pelvic</json:string>
<json:string>absolute risk reduction</json:string>
<json:string>duke university</json:string>
<json:string>small bowel complications</json:string>
<json:string>pelvic recurrences</json:string>
<json:string>para aortic nodes</json:string>
<json:string>upper pelvis relapse</json:string>
<json:string>implant duration</json:string>
<json:string>treatment technique</json:string>
<json:string>intracavitary insertions</json:string>
<json:string>upper pelvis</json:string>
<json:string>positive resection margin</json:string>
<json:string>parametrial involvement</json:string>
<json:string>bulky disease</json:string>
<json:string>lymph node metastasis</json:string>
<json:string>weekly cddp</json:string>
<json:string>cervical cancer patients</json:string>
<json:string>american brachytherapy society</json:string>
<json:string>appropriate method</json:string>
<json:string>chang gung university</json:string>
<json:string>cervical carcinoma</json:string>
<json:string>cancer patients</json:string>
<json:string>chang gung memorial hospital</json:string>
<json:string>radiation oncology</json:string>
<json:string>interstitial brachytherapy</json:string>
<json:string>loading pattern</json:string>
<json:string>dos</json:string>
<json:string>carcinoma</json:string>
<json:string>progression</json:string>
</teeft>
</keywords>
<author><json:item><name>E. Jones</name>
<affiliations><json:string>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>D. Brizel</name>
<affiliations><json:string>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>M. Dewhirst</name>
<affiliations><json:string>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>A. Alvarez</name>
<affiliations><json:string>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>A. Berchuck</name>
<affiliations><json:string>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>D. Clarke-Pearson</name>
<affiliations><json:string>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>G. Rodriquez</name>
<affiliations><json:string>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>J. Soper</name>
<affiliations><json:string>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
<json:item><name>L. Prosnitz</name>
<affiliations><json:string>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Abstract</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Abstract</json:string>
</originalGenre>
<qualityIndicators><score>1.897</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>578 x 786 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<keywordCount>1</keywordCount>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>1885</pdfWordCount>
<pdfCharCount>11536</pdfCharCount>
<pdfPageCount>2</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
<pii><json:string>S0360-3016(01)01940-X</json:string>
</pii>
<genre><json:string>abstract</json:string>
</genre>
<host><title>International Journal of Radiation Oncology, Biology, Physics</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>2001</publicationDate>
<issn><json:string>0360-3016</json:string>
</issn>
<pii><json:string>S0360-3016(00)X0106-X</json:string>
</pii>
<volume>51</volume>
<issue>3</issue>
<pages><first>63</first>
<last>64</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<categories><wos><json:string>science</json:string>
<json:string>radiology, nuclear medicine & medical imaging</json:string>
<json:string>oncology</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>oncology & carcinogenesis</json:string>
</scienceMetrix>
</categories>
<publicationDate>2001</publicationDate>
<copyrightDate>2001</copyrightDate>
<doi><json:string>10.1016/S0360-3016(01)01940-X</json:string>
</doi>
<id>E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability><p>©2001 Elsevier Science Inc.</p>
</availability>
<date>2001</date>
</publicationStmt>
<notesStmt><note type="content">Section title: Abstract</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
<author xml:id="author-0000"><persName><forename type="first">E.</forename>
<surname>Jones</surname>
</persName>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">D.</forename>
<surname>Brizel</surname>
</persName>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">M.</forename>
<surname>Dewhirst</surname>
</persName>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0003"><persName><forename type="first">A.</forename>
<surname>Alvarez</surname>
</persName>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0004"><persName><forename type="first">A.</forename>
<surname>Berchuck</surname>
</persName>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0005"><persName><forename type="first">D.</forename>
<surname>Clarke-Pearson</surname>
</persName>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0006"><persName><forename type="first">G.</forename>
<surname>Rodriquez</surname>
</persName>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0007"><persName><forename type="first">J.</forename>
<surname>Soper</surname>
</persName>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<author xml:id="author-0008"><persName><forename type="first">L.</forename>
<surname>Prosnitz</surname>
</persName>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
</author>
<idno type="istex">E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2</idno>
<idno type="DOI">10.1016/S0360-3016(01)01940-X</idno>
<idno type="PII">S0360-3016(01)01940-X</idno>
</analytic>
<monogr><title level="j">International Journal of Radiation Oncology, Biology, Physics</title>
<title level="j" type="abbrev">ROB</title>
<idno type="pISSN">0360-3016</idno>
<idno type="PII">S0360-3016(00)X0106-X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001"></date>
<biblScope unit="volume">51</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="supplement">S1</biblScope>
<biblScope unit="page" from="63">63</biblScope>
<biblScope unit="page" to="64">64</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2001</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<textClass><keywords scheme="keyword"><list><head>article-category</head>
<item><term>Abstract</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2001">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="abs" xml:lang="en"><item-info><jid>ROB</jid>
<aid>8564</aid>
<ce:pii>S0360-3016(01)01940-X</ce:pii>
<ce:doi>10.1016/S0360-3016(01)01940-X</ce:doi>
<ce:copyright type="full-transfer" year="2001">Elsevier Science Inc.</ce:copyright>
<ce:doctopics><ce:doctopic><ce:text>Abstract</ce:text>
</ce:doctopic>
</ce:doctopics>
</item-info>
<head><ce:dochead><ce:textfn>Abstract</ce:textfn>
</ce:dochead>
<ce:title>Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</ce:title>
<ce:author-group><ce:author><ce:given-name>E.</ce:given-name>
<ce:surname>Jones</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>D.</ce:given-name>
<ce:surname>Brizel</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>M.</ce:given-name>
<ce:surname>Dewhirst</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>A.</ce:given-name>
<ce:surname>Alvarez</ce:surname>
<ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>A.</ce:given-name>
<ce:surname>Berchuck</ce:surname>
<ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>D.</ce:given-name>
<ce:surname>Clarke-Pearson</ce:surname>
<ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>G.</ce:given-name>
<ce:surname>Rodriquez</ce:surname>
<ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>J.</ce:given-name>
<ce:surname>Soper</ce:surname>
<ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>L.</ce:given-name>
<ce:surname>Prosnitz</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1"><ce:label>1</ce:label>
<ce:textfn>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2"><ce:label>2</ce:label>
<ce:textfn>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</ce:textfn>
</ce:affiliation>
</ce:author-group>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA"><title>Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer</title>
</titleInfo>
<name type="personal"><namePart type="given">E.</namePart>
<namePart type="family">Jones</namePart>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D.</namePart>
<namePart type="family">Brizel</namePart>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M.</namePart>
<namePart type="family">Dewhirst</namePart>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A.</namePart>
<namePart type="family">Alvarez</namePart>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">A.</namePart>
<namePart type="family">Berchuck</namePart>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">D.</namePart>
<namePart type="family">Clarke-Pearson</namePart>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">G.</namePart>
<namePart type="family">Rodriquez</namePart>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J.</namePart>
<namePart type="family">Soper</namePart>
<affiliation>Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">L.</namePart>
<namePart type="family">Prosnitz</namePart>
<affiliation>Radiation Oncology, Duke University Medical Center, Durham, NC, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="abstract" displayLabel="Abstract"></genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">2001</dateIssued>
<copyrightDate encoding="w3cdtf">2001</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
</physicalDescription>
<note type="content">Section title: Abstract</note>
<subject><genre>article-category</genre>
<topic>Abstract</topic>
</subject>
<relatedItem type="host"><titleInfo><title>International Journal of Radiation Oncology, Biology, Physics</title>
</titleInfo>
<titleInfo type="abbreviated"><title>ROB</title>
</titleInfo>
<genre type="journal">journal</genre>
<originInfo><dateIssued encoding="w3cdtf">20011101</dateIssued>
</originInfo>
<identifier type="ISSN">0360-3016</identifier>
<identifier type="PII">S0360-3016(00)X0106-X</identifier>
<part><date>20011101</date>
<detail type="volume"><number>51</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>3</number>
<caption>no.</caption>
</detail>
<detail type="supplement"><number>S1</number>
<caption>Suppl.</caption>
</detail>
<extent unit="issue pages"><start>P1</start>
<end>P2</end>
</extent>
<extent unit="issue pages"><start>L1</start>
<end>L2</end>
</extent>
<extent unit="issue pages"><start>P3</start>
<end>P4</end>
</extent>
<extent unit="issue pages"><start>L3</start>
<end>L6</end>
</extent>
<extent unit="issue pages"><start>P5</start>
<end>P6</end>
</extent>
<extent unit="issue pages"><start>L7</start>
<end>L12</end>
</extent>
<extent unit="issue pages"><start>P7</start>
</extent>
<extent unit="issue pages"><start>L13</start>
<end>L16</end>
</extent>
<extent unit="issue pages"><start>P8</start>
</extent>
<extent unit="issue pages"><start>L17</start>
<end>L20</end>
</extent>
<extent unit="issue pages"><start>P9</start>
</extent>
<extent unit="issue pages"><start>L21</start>
<end>L26</end>
</extent>
<extent unit="issue pages"><start>P10</start>
</extent>
<extent unit="issue pages"><start>L27</start>
<end>L30</end>
</extent>
<extent unit="issue pages"><start>P11</start>
</extent>
<extent unit="issue pages"><start>L31</start>
<end>L36</end>
</extent>
<extent unit="issue pages"><start>P12</start>
</extent>
<extent unit="issue pages"><start>L37</start>
<end>L42</end>
</extent>
<extent unit="issue pages"><start>P13</start>
<end>P15</end>
</extent>
<extent unit="issue pages"><start>L43</start>
<end>L51</end>
</extent>
<extent unit="issue pages"><start>A1</start>
<end>A120</end>
</extent>
<extent unit="issue pages"><start>1</start>
<end>438</end>
</extent>
<extent unit="pages"><start>63</start>
<end>64</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2</identifier>
<identifier type="DOI">10.1016/S0360-3016(01)01940-X</identifier>
<identifier type="PII">S0360-3016(01)01940-X</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©2001 Elsevier Science Inc.</accessCondition>
<recordInfo><recordContentSource>ELSEVIER</recordContentSource>
<recordOrigin>Elsevier Science Inc., ©2001</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006C49 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 006C49 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:E7380432B38A115D4AA7B811EFFBE4E0F8DDB7C2
   |texte=   Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer

Phase I/II results using concurrent hyperthermia, radiotherapy, and chemotherapy for cervix cancer

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri